Updated Recommendations for Cost-effectiveness Studies-Reply

JAMA. 2017 Jan 3;317(1):90. doi: 10.1001/jama.2016.17839.

Authors

Gillian D Sanders¹, Peter J Neumann², Louise B Russell³

Affiliations

¹ Duke Clinical Research Institute, Duke University, Durham, North Carolina.
² Tufts Medical Center, Boston, Massachusetts.
³ Rutgers University, New Brunswick, New Jersey.

PMID: 28030697
DOI: 10.1001/jama.2016.17839

No abstract available

Publication types

Letter
Comment

MeSH terms

Cost-Benefit Analysis*
Humans